{
    "id": 29363,
    "fullName": "SLC12A2 - INSR",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "SLC12A2-INSR results from the fusion of SLC12A2 and INSR, and leads to transformation of cultured cells and activation of MAPK signaling in a reporter assay (PMID: 30279230). SLC12A2-INSR has been identified in MSI-high colorectal cancer (PMID: 30279230).",
            "references": [
                {
                    "id": 13140,
                    "pubMedId": 30279230,
                    "title": "Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability-High Colorectal Cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30279230"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 6558,
        "geneSymbol": "SLC12A2",
        "terms": [
            "SLC12A2",
            "BSC",
            "BSC2",
            "NKCC1",
            "PPP1R141"
        ]
    },
    "variant": "SLC12A2 - INSR",
    "createDate": "02/18/2019",
    "updateDate": "02/18/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 3643,
                "geneSymbol": "INSR",
                "terms": [
                    "INSR",
                    "CD220",
                    "HHF5"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 16042,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Linsitinib (OSI-906) inhibited growth of transformed cells expressing SLC12A2-INSR in culture, and inhibited tumor growth in xenograft models (PMID: 30279230).",
            "molecularProfile": {
                "id": 31382,
                "profileName": "SLC12A2 - INSR"
            },
            "therapy": {
                "id": 798,
                "therapyName": "Linsitinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 13140,
                    "pubMedId": 30279230,
                    "title": "Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability-High Colorectal Cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30279230"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31382,
            "profileName": "SLC12A2 - INSR",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}